Autologous mesenchymal stem cells transplantation protect experimental liver fibrosis rats from inhibition of hepatic stellate cell activation
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To investigate the inhibitory effects of mesenchymal stem cells (MSC) on hepatic fibrosis and activation degree of hepatic stellate cells (HSC) after transplantation. Methods: Ficoll-Hypaque density gradient centrifugation and adherent culture were performed to separate and purify bone marrow mesenchymal stem cells (BM-MSCs) from 4 months old SD rats. Liver fibrosis model of SD rats was induced by long-term intraperitoneal injection of low-dose of CCl4 for 8 weeks. A total of 18 rats were performed to make model, since 4 weeks after the modeling process, 9 of them were taken out to receive treatment of 6×106 MSCs for 4 weeks by tail vein injection, the remains were injected the same volume of saline without MSCs. The normal control group containing 9 rats were only given the same volume of saline injection for 4 weeks. ALT, AST, TBIL,and ALB levels of serum were determined by automatic biochemical analyzer every week from the start to the end of research in a total of 8. The localization and expression of alpha-smooth muscle actin (α-SMA), transforming growth factor beta 1 (TGF-β1), and collagen type Ⅰ (COL-Ⅰ) in liver tissues were analyzed by the immunohistochemical method. Density gradient centrifugation after situ perfusion and 326 nm of ultraviolet excitation together with α-SMA immunofluorescence staining were performed to isolate and identify HSC, respectively. The mRNA and protein expression levels of α-SMA and TGF-β1 in HSC were detected by qRT-PCR and Western blot, respectively. All above experiments were done at the end of the experiment at 8 weeks. Results: Compared with the model group, ALT, AST,and TBIL levels of serum; fibrosis and inflammation degree; α-SMA, TGF-β1,and COLⅠ expression levels in liver; the mRNA and protein expression levels of α-SMA and TGF-β1 in HSC were significantly reduced in the treatment group after MSCs transplantation. Conclusion: Liver fibrosis degree and liver function of SD rat were significantly reduced and improved after BM-MSC transplantation, respectively, which may be related to its inhibition of the activation level of HSC.

    Reference
    Related
    Cited by
Get Citation

Shi Qipeng, Guo Yuanyuan, Zhou Han, Cai Jie, Chen Nian, Li Jun, Zhang Lili. Autologous mesenchymal stem cells transplantation protect experimental liver fibrosis rats from inhibition of hepatic stellate cell activation[J].,2015,(7):981-987.

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 12,2015
  • Revised:
  • Adopted:
  • Online: July 12,2015
  • Published:
Article QR Code